Professional Documents
Culture Documents
Mineralocorticoid-
Aldosterone
Desoxycorticosterone
Glucocoticoid-
Cortisone
Hydrocortisone
Androgens-
DHEA,Androstenedione
Catecholamines-
Adrenaline
• NORMAL ADULT DAILY PRODUCTION
•Hydrocortisone •Prednislone
Dexamethasone
(Cortisol) •Methylprednislone
Betamethasone
•Triamicinolone
•Deflazacort
MINERALOCORTICOIDS
•DOCA(Desoxy-corticosterone actete)
•Aldosterone
•Fludrocortisone
Coopman’s classification-Based on chemical structure
Group D – Esters
Group D1 – Halogenated (less labile)
Aclometasone dipropionate
Betamethasone valerate
Betamethasone dipropionate
• Examples are :
• Calorigenic effect of glucagon.
• Lypolytic effect of catecholamines.
• Pressor effect of catecholamines.
• Bronchodilation by catecholamines.
Anti- inflammatory Action
Anti-allergic effect
Systemic form
• General principles for cortico-steroid use:
“The lowest effective dose for the least possible time”
Chiefly used in –
Route dose
im 20- 100mg
Prednisolone-
• More selective glucocorticoid
• 4 times more potent than hydrocortisone
• Fluid retention with high doses
• Less pituitary adrenal axis suppresion
• Also prevent its release in the gut, and they have a synergistic action with
5-HT3 antagonists.
• Temporomandibular joint (TMJ) disorder
• They are the main cause of chronic facial pain and a major cause of
disability (Horten 1953).
• Corticosteroids have been taken for more than one month during past one
year
CORTICOSTEROIDS IN ORTHODONTIC
TOOTH MOVEMENT
•Orthodontic tooth movement is by sequential reactions of the periodontal
tissue in response to biomechanical forces.
• The arachidonic acid metabolites also play an important role in the process
of bone remodeling during tooth movement
• Topical-
Hydrocortisone hemisuccinate (pellets of 2.5 mg)
Triamcinolone acetonide (adhesive paste containing 0.1% of the steroid).
• Systemic treatment -
-Prednisone therapy 40 mg/day for 1 week
-1.0 mg/kg a day as a single dose in severe RAS patients and
gradually tapered after 7-14 days.
BEHCET’S DISEASE
• Minor EM –
20 to 40 mg/day of Triamicinolone
acetonide for 4 to 6 days
• Short course of TC –
• Accelerates remission without producing adverse effects
• Ulcerative disease that have tendency to remit spontaneously
•Eg RAS, some cases of EM, drug induced ulceration
• Intralesional triamcinolone
acetonide (4 mg/mL)
• STEROIDS IN SALIVARY GLAND
DISORDERS
• Mucocele
• 0.05% clobetasol propionate 3 times a
day for 4 weeks in a mucosal adhesive base.
• Intralesional injections have also been
tried with success
STERIODS IN NEURALGIA
•The initial symptomatic relief the anti- inflammatory action of the steroid
• Biweekly submucosal injections combination of –
Systemic-
• Therapy with Hydrocortisone 25 mg orally QID
• Triamicinolone or 90mg of Dexamethasone supplemented with biweekly
intraleisonal injections.
• Medical emergencies in Dental
Practice
Adrenal crisis prophylaxis
• Hydrocortisone i.v. initially.
• The dose can be decreased by one third to one half the dose daily until a
maintenance dose of 20 mg in the morning and 10 mg in the afternoon or
at night is attained.
• Some patients may need only a dose of 20 mg/day total (i.e., 20 mg every
morning, or 15 mg in the morning and 5 mg in the afternoon or at night).
Anaphylatic shock
• They have a delayed onset of 4 to 6 hours.
• Any patient taking > 20 -25 mg /day hydrocortisone or equivalent dose for
longer than 2-3 week.
• 20mg hydrocortisone/day reduction every week
Glucocorticoid :
1. Cushing’s habitus: round face,
narrow mouth,
supraclavicular hump,
obesity of trunk with relatively thin limbs.
• Fragile skin & purple striae :
-typically on thighs & lower abdomen
-easy bruising
-telengiactasis
-hirstuism,
-cutaneous atrophy due to topical use
telengiactasis
Psychiatric disturbances : mild euphoria
nervousness
decreased sleep
mood changes
depressive illness
Suppression of hypothalamo-pitutary axis (HPA) :